This is a ready-to-use log for tracking information requests (IRs) and discipline review letters (DRLs) received during health authority review of a marketing application or a supplement. It exists because IRs are easy to treat casually, short deadlines, an informal-feeling email, and treating one casually is exactly how a minor clarifying question turns into a documented deficiency. Keep one log per active application. Replace every <<FILL: ...>> placeholder. A field guide and a filled specimen follow. Read alongside managing health authority interactions for the reasoning behind treating every IR as a reviewed, on-the-record response.
Why this log exists
Every IR response becomes part of the review record, whether it is two sentences or two pages. A team without a single tracked list of open IRs risks three failure modes at once: a deadline missed because no one owned it, a response that went out without quality or regulatory review touching a CMC or data-integrity statement, and a pattern of small, rushed answers that individually look fine but collectively signal a program that is not in control. This log makes every IR visible, owned, and reviewed before it leaves the building, and gives the team a single place to see whether informal review pressure is building toward a deficiency.
Field table
| Field | Format | Required | Who enters | When |
|---|---|---|---|---|
| IR / DRL number | <<FILL: scheme, e.g. IR-2026-014>> | Yes | Regulatory lead | On receipt |
| Date received | Date | Yes | Regulatory lead | On receipt |
| Discipline | Clinical / CMC / Nonclinical / Statistics / Facility / Labeling / other | Yes | Regulatory lead | On receipt |
| Reviewer question | Free text, verbatim or a close paraphrase | Yes | Regulatory lead | On receipt |
| Deadline | Date | Yes | Regulatory lead | On receipt |
| Owner (responsible SME) | Named role / person | Yes | Regulatory lead | On receipt |
| Response status | Not started / drafting / QA review / regulatory review / submitted | Yes | Owner | Updated through |
| Date submitted | Date | Yes (at closure) | Regulatory lead | At submission |
| QA / regulatory review sign-off | Name and date, both required for a CMC, validation, or data-integrity question | Yes | QA and regulatory | Before submission |
| Outcome | Accepted / follow-up requested / escalated toward a deficiency | Yes (once known) | Regulatory lead | After the agency’s next communication |
Tracker table
| IR / DRL # | Date received | Discipline | Reviewer question | Deadline | Owner | Status | Date submitted | QA / Reg sign-off | Outcome |
|---|---|---|---|---|---|---|---|---|---|
<<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> |
<<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> |
Instructions
- Log every IR or DRL the same working day it is received, before anyone starts drafting a response. An IR that exists only in someone’s inbox is an IR the program cannot see.
- Confirm the deadline against the actual letter, not a verbal summary, and flag anything under
<<FILL: number>>business days to the regulatory lead immediately. - Assign a named owner, not a function or a department. A response with no named person behind it does not get written on time.
- Route every response touching CMC, validation, data integrity, or facility status through QA review before regulatory submits it. A rushed or inaccurate answer on these topics is the most common way a small question becomes a deficiency.
- If the deadline cannot realistically be met, negotiate an extension with the regulatory project manager before the deadline passes, and log the negotiated date; do not let a response go silent and log itself as “late” after the fact.
- Close the outcome field only once the agency’s reaction is known, whether that is silence read as acceptance, a follow-up question, or the issue reappearing in a later communication.
- Review the open rows at a standing cadence (
<<FILL: weekly during active review>>) so a cluster of IRs on the same topic is caught and escalated rather than answered one at a time as if unrelated.
Retention
Retain this log for the life of the application plus the applicable records-retention period in your jurisdiction. Confirm the retention period against <<FILL: records retention SOP>>. Keep the log in a controlled, queryable system rather than a personal spreadsheet, so it survives a change in regulatory personnel.
Acceptance criteria
- Every IR and DRL received appears in the log the same working day, with a deadline and a named owner.
- No CMC, validation, data-integrity, or facility-status response left the organization without a documented QA and regulatory sign-off.
- No deadline was missed without a documented, timely extension request.
- A cluster of related IRs was identified and escalated, not answered as isolated questions.
- The outcome field is current for every closed row, so the team can see whether IR responses are actually resolving reviewer concerns or generating follow-ups.
Filled specimen
Illustrative entries for an example BLA under active review. Replace with your own.
| IR / DRL # | Date received | Discipline | Reviewer question | Deadline | Owner | Status | Date submitted | QA / Reg sign-off | Outcome |
|---|---|---|---|---|---|---|---|---|---|
| IR-2026-041 | 03 Aug 2026 | CMC / Analytical | Clarify the forced-degradation conditions used to establish specificity of the release dissolution method | 10 Aug 2026 | J. Reyes (Analytical) | Submitted | 08 Aug 2026 | R. Gomez (QA), 07 Aug 2026; A. Lindgren (Reg), 08 Aug 2026 | Accepted, no follow-up |
| IR-2026-044 | 12 Aug 2026 | Facility / Quality | Explain how deviations open at the time of a cited batch’s release were dispositioned | 19 Aug 2026 | R. Gomez (QA) | Submitted | 18 Aug 2026 | R. Gomez (QA), 17 Aug 2026; A. Lindgren (Reg), 18 Aug 2026 | Follow-up requested: agency asked for the full population of batches released with an open deviation in the prior 12 months |
| IR-2026-047 | 20 Aug 2026 | Statistics | Provide the pre-specified handling of a single missing endpoint assessment in the primary analysis | 27 Aug 2026 | K. Osei (Biostatistics) | QA review | (pending) | R. Gomez (QA), in progress | (pending) |
The value shows in IR-2026-044: because the response was logged, QA-reviewed, and tracked, the team caught that the answer as drafted described only the cited batch, and the follow-up question the agency then asked (the full 12-month population) was exactly the kind of scope expansion the CRL resubmission plan template is built to handle if it later becomes a facility deficiency rather than staying at the IR stage. Logging IR-2026-047 as still in QA review, rather than letting it sit in an inbox, is what keeps a five-day statistics deadline from being missed.
Common inspection findings this log prevents
- An IR response that went out with no QA review, later shown to be inconsistent with the batch record or the underlying data.
- A missed IR deadline discovered only when the agency’s next communication referenced it as unanswered.
- A pattern of related IRs on the same underlying issue, answered individually with no one noticing the pattern until it became a deficiency.
- A negotiated extension that exists only as an email thread, with no record in the application’s regulatory history.
How to adapt this log
- Set your ID scheme and point the retention line to your records-retention SOP.
- If your organization runs multiple applications at once, key the IR numbers by application so the logs do not collide.
- Add a column for the review discipline’s specific reviewer or division contact if your program interacts with more than one review division.
- Tie a facility- or data-integrity-flavored IR directly into a CAPA record once it is clear the issue is systemic, rather than letting it live only as an IR response.